Editorial: The gut-kidney axis: A potential drug target for treating kidney diseases.

Front Pharmacol

Department of Pathology, University at Buffalo, Buffalo, NY, United States.

Published: September 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490406PMC
http://dx.doi.org/10.3389/fphar.2022.1012890DOI Listing

Publication Analysis

Top Keywords

editorial gut-kidney
4
gut-kidney axis
4
axis potential
4
potential drug
4
drug target
4
target treating
4
treating kidney
4
kidney diseases
4
editorial
1
axis
1

Similar Publications

Editorial: Podocyte Pathology and Nephropathy-An Update.

Front Endocrinol (Lausanne)

July 2019

Department of Pathophysiology, Faculty of Pharmacy, Medical University of Gdansk, Gdańsk, Poland.

View Article and Find Full Text PDF

Chronic Kidney Disease: The Gut-Kidney Connection?

Integr Med (Encinitas)

April 2017

Among strategies for both the prevention and treatment of renal disease, reduction of uremic toxins and bacterial lipopolysaccharides that activates toll-like receptors and improvement in the composition of the microbiome represent valuable and clinically proven approaches. Dietary components-specifically soluble and insoluble prebiotic fibers; phytochemicals such as curcumin, berberine, epigallocatechin gallate, and withanolides that modulate gut immune function and improve detoxification of uremic toxins; and supplemental, clinically tested probiotics-constitute a family of therapeutics that can positively affect patients. In addition, the bidirectional relationship of the microbiome to kidney disease is an important concept in designing a personalized approach to the management of kidney disease, especially with regard to its relationship to cardiovascular disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!